ARQT: Arcutis Biotherapeutics, Inc.
About
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.
Current Value
$12.231 Year Return
Current Value
$12.231 Year Return
Key Details
Market Cap
$1.45B
P/E Ratio
-6.93
1Y Stock Return
454.24%
1Y Revenue Growth
182.84%
Dividend Yield
0.00%
Price to Book
9.3
Strategies that include ARQT
Stock's related to ARQT
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SWTX | 37.51% | $3.11B | +32.25% | 0.00% |
| ARWR | 36.77% | $3.28B | +5.66% | 0.00% |
| OCUL | 34.95% | $1.54B | +190.77% | 0.00% |
| SANA | 34.92% | $636.32M | -30.32% | 0.00% |
| XNCR | 34.53% | $1.88B | +40.38% | 0.00% |
| PLRX | 34.21% | $943.84M | +7.48% | 0.00% |
| KROS | 34.18% | $2.30B | +78.23% | 0.00% |
| GBIO | 33.41% | $94.85M | -5.96% | 0.00% |
| PGEN | 32.40% | $266.19M | -25.50% | 0.00% |
| PDSB | 32.33% | $80.43M | -59.28% | 0.00% |
| VYGR | 32.16% | $378.56M | -7.85% | 0.00% |
| FATE | 32.00% | $337.13M | +16.54% | 0.00% |
| SAFE | 31.92% | $1.51B | -4.52% | 3.35% |
| RNA | 31.89% | $4.93B | +414.32% | 0.00% |
| FLUX | 31.43% | $30.36M | -46.78% | 0.00% |
| RCKT | 30.90% | $1.31B | -41.78% | 0.00% |
| BCRX | 30.84% | $1.53B | +19.22% | 0.00% |
| PSTX | 30.68% | $908.37M | +225.87% | 0.00% |
| DXYZ | 30.27% | - | - | 0.00% |
| PGY | 30.12% | $796.22M | -37.44% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CHKP | <0.01% | $20.04B | +25.24% | 0.00% |
| EMN | -0.06% | $12.09B | +22.84% | 3.10% |
| CREG | 0.06% | $6.32M | -35.67% | 0.00% |
| AJG | -0.06% | $67.57B | +24.40% | 0.58% |
| LEG | 0.07% | $1.71B | -47.42% | 8.07% |
| MANU | 0.10% | $2.93B | -11.97% | 0.00% |
| WLKP | -0.11% | $840.09M | +8.96% | 7.91% |
| NOC | 0.11% | $70.63B | +0.92% | 1.66% |
| INFN | -0.13% | $1.57B | +57.62% | 0.00% |
| LUNA | 0.15% | $66.56M | -67.44% | 0.00% |
| INTC | 0.15% | $103.21B | -43.49% | 1.58% |
| FENG | -0.15% | $13.37M | +73.05% | 0.00% |
| SEG | 0.16% | $395.76M | +20.95% | 0.00% |
| MMC | -0.16% | $114.45B | +18.08% | 1.31% |
| NLOP | 0.20% | $474.30M | +69.38% | 0.00% |
| VIRT | -0.22% | $3.25B | +106.50% | 2.53% |
| CMG | -0.23% | $82.49B | +36.40% | 0.00% |
| DGX | -0.24% | $18.03B | +17.47% | 1.83% |
| OCSL | 0.25% | - | - | 13.36% |
| ACGL | -0.26% | $37.36B | +27.37% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CYD | -14.01% | $384.89M | +1.29% | 4.07% |
| ALL | -13.39% | $54.12B | +47.42% | 1.79% |
| TEM | -11.63% | $9.91B | 0.00% | 0.00% |
| CHD | -9.93% | $27.25B | +16.97% | 1.02% |
| OXBR | -9.47% | $24.28M | +267.92% | 0.00% |
| AFL | -8.59% | $61.89B | +34.65% | 1.80% |
| WHLM | -8.37% | $20.47M | -13.32% | 0.00% |
| USM | -8.31% | $5.41B | +43.98% | 0.00% |
| COR | -8.28% | $48.29B | +22.63% | 0.82% |
| MCK | -7.88% | $78.87B | +35.27% | 0.43% |
| RNR | -7.71% | $14.93B | +37.70% | 0.54% |
| MNOV | -7.48% | $116.73M | +36.78% | 0.00% |
| DBX | -7.41% | $8.79B | +0.21% | 0.00% |
| CME | -7.35% | $84.90B | +9.89% | 1.92% |
| PGR | -7.13% | $154.68B | +61.58% | 0.43% |
| TPST | -6.99% | $41.52M | -71.85% | 0.00% |
| APRE | -6.98% | $16.96M | -15.68% | 0.00% |
| BTCT | -6.98% | $60.65M | +335.42% | 0.00% |
| RAMP | -6.80% | $2.06B | -6.54% | 0.00% |
| CYCN | -6.77% | $6.34M | +3.08% | 0.00% |
ETF's related to ARQT
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 45.02% | $7.29B | 0.35% |
| PTH | 39.21% | $141.39M | 0.6% |
| GNOM | 39.12% | $79.38M | 0.5% |
| PBE | 37.78% | $263.25M | 0.58% |
| IBB | 37.73% | $6.97B | 0.45% |
| ARKG | 34.95% | $1.27B | 0.75% |
| IWC | 34.73% | $996.57M | 0.6% |
| IWO | 33.68% | $13.37B | 0.24% |
| XPH | 33.48% | $164.49M | 0.35% |
| YYY | 33.09% | $550.05M | 4.6% |
| IHE | 32.73% | $612.43M | 0.39% |
| KOMP | 32.66% | $2.22B | 0.2% |
| RSPA | 32.55% | $278.68M | 0% |
| FBT | 32.45% | $1.19B | 0.56% |
| CWB | 32.31% | $4.29B | 0.4% |
| EDOC | 32.27% | $43.10M | 0.68% |
| PBW | 32.23% | $318.59M | 0.65% |
| FLGB | 32.10% | $664.92M | 0.09% |
| ISCG | 32.09% | $680.01M | 0.06% |
| IWM | 31.86% | $80.66B | 0.19% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BILZ | -0.20% | $541.42M | 0.14% |
| UNG | 0.39% | $856.92M | 1.06% |
| SHV | 0.89% | $18.61B | 0.15% |
| KRBN | -1.28% | $235.35M | 0.85% |
| XBIL | -1.30% | $633.44M | 0.15% |
| DBMF | 1.43% | $1.04B | 0.85% |
| CLOI | -1.45% | $749.05M | 0.4% |
| TAIL | -2.03% | $68.19M | 0.59% |
| KCCA | -2.16% | $219.07M | 0.87% |
| JBBB | -2.20% | $1.35B | 0.49% |
| IBDP | 2.24% | $2.03B | 0.1% |
| TBLL | 2.60% | $1.94B | 0.08% |
| CSHI | -2.78% | $493.76M | 0.38% |
| TBIL | 3.19% | $4.42B | 0.15% |
| BOXX | 3.48% | $4.45B | 0.1949% |
| XHLF | 3.57% | $900.10M | 0.03% |
| FMF | 3.61% | $248.49M | 0.95% |
| DBA | -3.91% | $787.55M | 0.93% |
| GBIL | 4.01% | $5.68B | 0.12% |
| SGOV | -4.08% | $27.99B | 0.09% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -25.54% | $365.42M | 1.43% |
| USDU | -24.47% | $210.52M | 0.5% |
| UUP | -22.76% | $376.91M | 0.77% |
| CTA | -15.05% | $367.83M | 0.76% |
| VIXY | -14.99% | $195.31M | 0.85% |
| EQLS | -9.34% | $8.93M | 1% |
| KMLM | -9.08% | $344.74M | 0.9% |
| TPMN | -8.99% | $40.42M | 0.65% |
| WEAT | -8.87% | $119.27M | 0.28% |
| BIL | -8.65% | $34.29B | 0.1356% |
| MINT | -8.17% | $11.69B | 0.35% |
| BSCO | -8.00% | $2.27B | 0.1% |
| AGZD | -7.31% | $132.76M | 0.23% |
| CORN | -4.40% | $59.94M | 0.2% |
| JUCY | -4.32% | $325.86M | 0.6% |
| SGOV | -4.08% | $27.99B | 0.09% |
| DBA | -3.91% | $787.55M | 0.93% |
| CSHI | -2.78% | $493.76M | 0.38% |
| JBBB | -2.20% | $1.35B | 0.49% |
| KCCA | -2.16% | $219.07M | 0.87% |
News
Finnhub
Strategic appointments support further growth and position Company for future success WESTLAKE VILLAGE, Calif., Dec. 03, 2024 -- Arcutis Biotherapeutics, Inc. , a commercial-stage...
Yahoo
The mean of analysts' price targets for Arcutis Biotherapeutics (ARQT) points to a 60.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Yahoo
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Yahoo
When a stock breaks out above the 200-day simple moving average, good things could be on the horizon. How should investors react?
Yahoo
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Yahoo
Arcutis Biotherapeutics (ARQT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.